Bevacizumab: a new potential therapeutic option in sinusoidal obstruction syndrome.

Authors	Mehmet Ali Nahit Şendur, Sercan Aksoy, Zafer Arık, Şebnem Yaman, Nuriye Yıldırım Özdemir, Dogan Uncu, Nurullah Zengin
Journal	Asian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 12 Issue 8 Pg. 2147-8 ( 2011) ISSN: 2476-762X [Electronic] Thailand
PMID	22292668 (Publication Type: Letter)
Chemical References	Antibodies, Monoclonal, Humanized Antineoplastic Agents Bevacizumab
Topics	Antibodies, Monoclonal, Humanized (adverse effects, therapeutic use) Antineoplastic Agents (adverse effects, therapeutic use) Bevacizumab Hepatic Veno-Occlusive Disease (drug therapy, pathology) Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!